Literature DB >> 20947483

Smoking habits in elderly lung cancer patients: still no changes in epidemiology? A single-center experience.

Regina Gironés Sarrió1, María Dolores Torregrosa, Pedro López, José Gómez-Codina, Rafael Rosell.   

Abstract

PURPOSE: Our goal was to describe the clinical, histological, and epidemiological characteristics of lung cancer diagnoses in people ≥70 years of age.
MATERIALS AND METHODS: Information on patients diagnosed with lung cancer from January 2006 to February 2008 was prospectively collected from the outpatient oncology department at a regional hospital. A total of 83 patients (97.6% men; mean age 77 years) were studied. There was a higher ratio of men to women than that reported in younger populations. Mean age was higher than that reported for randomized studies: 65.1% were ≥75 years old. Patients >80 years constituted 28.9% of the study population. Most patients (96.4%) had a history of smoking; they were predominantly former smokers (72.5% vs. 27.5%).
RESULTS: The most common histological types were squamous cell (61.3%) and small cell (14.5%) carcinoma. Metastasis was present in 36.1% of patients. Stage was significantly associated with survival (logrank p < 0.001). There was no association between age and survival. Squamous cell lung cancer was associated with a better survival (p = 0.003).
CONCLUSIONS: Elderly lung cancer patients who attended clinical practice were older than those included in prospective studies. The predominance of men and squamous cell carcinoma is associated with a smoking history. The epidemiological and histological patterns of younger patients have changed, possibly in relation to changes in smoking habits. The translation of these changes to elderly patients will be evidenced in the future. Only prospective epidemiologic studies will determine whether smoking habits are changing epidemiology in elderly lung cancer patients.

Entities:  

Mesh:

Year:  2010        PMID: 20947483     DOI: 10.1007/s12094-010-0578-5

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  32 in total

1.  Should elderly non-small-cell lung cancer patients be offered elderly-specific trials? Results of a pooled analysis from the North Central Cancer Treatment Group.

Authors:  Aminah Jatoi; Shauna Hillman; Philip Stella; Erin Green; Alex Adjei; Suresh Nair; Edith Perez; Bipinkur Amin; Steven E Schild; Rene Castillo; James R Jett
Journal:  J Clin Oncol       Date:  2005-12-20       Impact factor: 44.544

2.  Smoking and lung cancer in Harbin, northeast China.

Authors:  J Hu; C Galeone; R Lui; C Pelucchi; C La Vecchia; E Negri
Journal:  Ann Oncol       Date:  2005-07-08       Impact factor: 32.976

Review 3.  Biology of aging and cancer.

Authors:  Vladimir N Anisimov
Journal:  Cancer Control       Date:  2007-01       Impact factor: 3.302

4.  The ELVIS trial: a phase III study of single-agent vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer. Elderly Lung Cancer Vinorelbine Italian Study.

Authors:  C Gridelli
Journal:  Oncologist       Date:  2001

5.  Clinical surrogate markers of survival in advanced non-small cell lung cancer (NSCLC) patients treated with second-third line erlotinib.

Authors:  Susana Cedrés; Aleix Prat; Pablo Martínez; Esther Pallisa; Gemma Sala; Jordi Andreu; J M del Campo; Isela Quispe; José Baselga; Enriqueta Felip
Journal:  Lung Cancer       Date:  2009-02-23       Impact factor: 5.705

Review 6.  Science of cancer and aging.

Authors:  Irmgard Irminger-Finger
Journal:  J Clin Oncol       Date:  2007-05-10       Impact factor: 44.544

7.  Clinical analysis of multiple primary malignancies in the elderly.

Authors:  Andrea Luciani; G Ascione; D Marussi; S Oldani; S Caldiera; S Bozzoni; C Codecà; S Zonato; D Ferrari; P Foa
Journal:  Med Oncol       Date:  2008-05-16       Impact factor: 3.064

8.  Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

Authors:  Giorgio Vittorio Scagliotti; Purvish Parikh; Joachim von Pawel; Bonne Biesma; Johan Vansteenkiste; Christian Manegold; Piotr Serwatowski; Ulrich Gatzemeier; Raghunadharao Digumarti; Mauro Zukin; Jin S Lee; Anders Mellemgaard; Keunchil Park; Shehkar Patil; Janusz Rolski; Tuncay Goksel; Filippo de Marinis; Lorinda Simms; Katherine P Sugarman; David Gandara
Journal:  J Clin Oncol       Date:  2008-05-27       Impact factor: 44.544

Review 9.  The changing epidemiology of lung cancer in Europe.

Authors:  Maryska L G Janssen-Heijnen; Jan-Willem W Coebergh
Journal:  Lung Cancer       Date:  2003-09       Impact factor: 5.705

10.  Lung cancer and treatment in elderly patients: the Achilles Study.

Authors:  Mariano Provencio; Carlos Camps; Vicente Alberola; Bertomeu Massutti; Nuria Viñolas; Dolores Isla; Manuel Dómine; Isabel Millán; Manuel Cobo; Rafael Rosell
Journal:  Lung Cancer       Date:  2009-02-04       Impact factor: 5.705

View more
  1 in total

1.  Desire for Information in the Elderly: Interactions with Patients, Family, and Physicians.

Authors:  Regina Gironés
Journal:  J Cancer Educ       Date:  2015-12       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.